Mucosal Vaccination With a Self-Adjuvanted Lipopeptide Is Immunogenic and Protective Against Mycobacterium Tuberculosis

doi 10.1021/acs.jmedchem.9b00832.s001
Full Text
Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

Protective Immunity Against Ocular Herpes Infection and Disease Induced by Highly Immunogenic Self-Adjuvanting Glycoprotein D Lipopeptide Vaccines

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2007English

CD44 Is a Macrophage Binding Site for Mycobacterium Tuberculosis That Mediates Macrophage Recruitment and Protective Immunity Against Tuberculosis

Journal of Clinical Investigation
Medicine
2003English

Early BCG Vaccination Is Unrelated to Pulmonary Immunity Against Mycobacterium Tuberculosis in Adults

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2014English

Vaccination With the T Cell Antigen MTB 8.4 Protects Against Challenge With Mycobacterium Tuberculosis

Journal of Immunology
AllergyImmunology
2001English

Vaccination Against Tuberculosis

The Lancet
Medicine
1954English

NK1.1+ Cells and IL-22 Regulate Vaccine-Induced Protective Immunity Against Challenge With Mycobacterium Tuberculosis

Journal of Immunology
AllergyImmunology
2012English

Protective Vaccination Against Pneumococci

Pneumologie
MedicinePulmonaryRespiratory Medicine
2001English

Protective and Therapeutic Efficacy of Mycobacterium Smegmatis Expressing HBHA-hIL12 Fusion Protein Against Mycobacterium Tuberculosis in Mice

PLoS ONE
Multidisciplinary
2012English

Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium Tuberculosis

Science
MultidisciplinaryPhilosophy of ScienceHistory
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy